Filing Details

Accession Number:
0001562180-23-000494
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-18 20:03:46
Reporting Period:
2023-01-13
Accepted Time:
2023-01-18 20:03:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603756 Axonics Inc. AXNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1359446 Jr J Alfred Ford 26 Technology Drive
Irvine CA 92618
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-13 8,509 $1.42 45,282 No 4 M Direct
Common Stock Acquisiton 2023-01-13 1,899 $1.63 47,181 No 4 M Direct
Common Stock Acquisiton 2023-01-13 9,310 $25.82 56,491 No 4 M Direct
Common Stock Acquisiton 2023-01-13 16,297 $14.19 72,788 No 4 M Direct
Common Stock Disposition 2023-01-13 15,292 $65.90 57,496 No 4 S Direct
Common Stock Disposition 2023-01-13 17,108 $66.69 40,388 No 4 S Direct
Common Stock Disposition 2023-01-13 3,615 $67.18 36,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-01-13 9,310 $0.00 9,310 $25.82
Common Stock Stock Option (Right to Buy) Disposition 2023-01-13 16,297 $0.00 16,297 $14.19
Common Stock Stock Option (Right to Buy) Disposition 2023-01-13 1,899 $0.00 1,899 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2023-01-13 8,509 $0.00 8,509 $1.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,655 2029-12-12 No 4 M Direct
0 2029-01-30 No 4 M Direct
0 2028-03-30 No 4 M Direct
0 2027-11-15 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $65.05 USD to $66.04 USD; the price reported above reflects the weighted average sale price.
  2. This transaction was executed in multiple trades at prices ranging from $66.085 USD to $67.08 USD; the price reported above reflects the weighted average sale price.
  3. This transaction was executed in multiple trades at prices ranging from $67.13 USD to $67.215 USD; the price reported above reflects the weighted average sale price.
  4. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date.
  5. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
  6. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  7. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on November 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of November 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.